Regulatory Concerns for the Crops Developed Using Genome Editing Tools
New breeding technologies like ZFNs, TALENs, and CRISPR does not fall under the definition of a GMO under regulatory regimes in many countries. The United States Department of Agriculture (USDA) has stated stated that CRISPR/Cas9 edited crops can be cultivated and sold free from regulatory monitoring (Waltz, 2018). This can save several million dollars on getting regulations of GMO crops for the field test and data collections. In addition, it also reduces time as it usually takes several years to release a GMO crop. It also will remove the uncertainty of consuming GMO crops among the public. To date, there are five crops edited with CRISPR/Cas9 approach in the pipeline that USDA has declared not to regulate including a white button mushroom (Agaricus bisporus); resistance to browning was developed using CRISPR/Cas9 by knocking out a gene polyphenol oxidase (PPO) (Waltz, 2016). Similarly, waxy corn (Z. mays) with enriched amylopectin has been developed by inactivating an endogenous waxy gene Wx1 and has also been exempted from GMO regulations. Green bristlegrass (Setaria viridis) with delayed flowering time achieved by deactivating the S. viridis homolog of the Z. mays ID1 gene, Yield10 Bioscience edited camelina for increased oil content and drought tolerant soybean (Glycine max) edited for Drb2a and Drb2b genes will also not be subject to regulatory evaluation.
CC BY 4.0. "CRISPR for Crop Improvement: An Update Review" by Jaganathan D, Ramasamy K, Sellamuthu G et al., Frontiers in plant science (2018). https://doi.org/10.3389/fpls.2018.00985. Licensed under CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Peer-reviewed and open access; full text from PubMed Central (PMC6056666). Headings and layout adapted for reading; figures and tables are in the original.